₹2225.67
(Inclusive of all Taxes)
Get Free delivery (₹99) with



Composition :
Manufacturer/Marketer :
Consume Type :
Return Policy :
About Eurelix PFS 0.25 mg Injection 0.5 ml
Eurelix PFS 0.25 mg Injection 0.5 ml belongs to the class of drugs called hormones used to treat female infertility in women. Infertility is unable to become pregnant after trying for a year. Female infertility may be caused due to different factors affecting ovulation (release of an egg from the ovary), fertilization (fusion of sperm and egg), and implantation (fertilized egg attaches to uterus lining).
If eggs are released too early during fertility treatment, they may not be suitable for fertilization. Eurelix PFS 0.25 mg Injection 0.5 ml contains Cetrorelix, an anti-gonadotropin-releasing hormone that works by blocking a natural hormone in the body. Thereby, it inhibits premature ovulation (the release of eggs from the ovary too early).
Take Eurelix PFS 0.25 mg Injection 0.5 ml as prescribed by your doctor. You are advised to take Eurelix PFS 0.25 mg Injection 0.5 ml for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience itching, redness, or swelling at the site of injection, headache, or nausea. Most of these side effects of Eurelix PFS 0.25 mg Injection 0.5 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Eurelix PFS 0.25 mg Injection 0.5 ml or any other medicines, please tell your doctor. Avoid taking Eurelix PFS 0.25 mg Injection 0.5 ml if you are pregnant or breastfeeding, and consult a doctor before taking Eurelix PFS 0.25 mg Injection 0.5 ml. If you experience lower stomach pain with nausea or vomiting, please consult a doctor immediately as these might be signs of the ovarian hyper-stimulation syndrome (OHSS).
Uses of Eurelix PFS 0.25 mg Injection 0.5 ml
Eurelix PFS 0.25 mg Injection 0.5 ml used in the treatment of Female infertility. The detailed uses of Eurelix PFS 0.25 mg Injection 0.5 ml are as follows:

Have a query?
Directions for Use
Key Benefits
Eurelix PFS 0.25 mg Injection 0.5 ml contains Cetrorelix, a hormone that blocks a natural hormone in the body. Thereby, it inhibits premature ovulation (release of eggs from the ovary too early). If eggs are released too early during fertility treatment, they may not be suitable for fertilization.
How Eurelix PFS 0.25 mg Injection 0.5 ml Works
Storage
What if I have taken an overdose of Eurelix PFS 0.25 mg Injection 0.5 ml
Drug Warnings
If you are allergic to Eurelix PFS 0.25 mg Injection 0.5 ml or any other medicines, please tell your doctor. If you have any kidney or liver problems, inform your doctor before taking Eurelix PFS 0.25 mg Injection 0.5 ml. Avoid taking Eurelix PFS 0.25 mg Injection 0.5 ml if you are pregnant or breastfeeding, and consult a doctor before taking Eurelix PFS 0.25 mg Injection 0.5 ml. You are recommended to remove Eurelix PFS 0.25 mg Injection 0.5 ml from the refrigerator 30 minutes before using it. Wash your hands and inject Eurelix PFS 0.25 mg Injection 0.5 ml under the skin of the belly as instructed by your doctor. If you experience lower stomach pain with nausea or vomiting, please consult a doctor immediately as these might be signs of ovarian hyper-stimulation syndrome (OHSS).
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
RXSamarth Life Sciences Pvt Ltd
₹17
(₹17.0 per unit)
RXEris Life Sciences Ltd
₹1607.13
(₹321.43/ 1ml)
RX₹650
(₹650.0 per unit)
Alcohol
Caution
The interaction of Eurelix PFS 0.25 mg Injection 0.5 ml with alcohol is unknown. Please consult a doctor before consuming alcohol while using Eurelix PFS 0.25 mg Injection 0.5 ml.
Pregnancy
Unsafe
Eurelix PFS 0.25 mg Injection 0.5 ml is a category X pregnancy drug and is not recommended for use during pregnancy as it may cause miscarriage, stillbirth, or birth defects. However, please consult a doctor if you are pregnant.
Breast Feeding
Unsafe
Eurelix PFS 0.25 mg Injection 0.5 ml is contraindicated in breastfeeding women. Please consult a doctor if you are breastfeeding.
Driving
Safe if prescribed
Eurelix PFS 0.25 mg Injection 0.5 ml usually does not affect your ability to drive or operate machinery.
Liver
Caution
If you have any concerns regarding the use of Eurelix PFS 0.25 mg Injection 0.5 ml in patients with Liver problems, please consult a doctor.
Kidney
Caution
If you have any concerns regarding using Eurelix PFS 0.25 mg Injection 0.5 ml in patients with kidney problems, please consult a doctor. Avoid using Eurelix PFS 0.25 mg Injection 0.5 ml if you have severe kidney disease.
Children
Unsafe
Eurelix PFS 0.25 mg Injection 0.5 ml is not recommended for children.
Heart
Caution
Limited information was available regarding the use of Eurelix PFS 0.25 mg Injection 0.5 ml in patients with heart problems. Please consult your doctor before receiving Eurelix PFS 0.25 mg Injection 0.5 ml.
Geriatrics
Caution
Limited information is available regarding the use of Eurelix PFS 0.25 mg Injection 0.5 ml in elderly patients. If you have any concerns about the usage of Eurelix PFS 0.25 mg Injection 0.5 ml in geriatrics, please consult your doctor.
Eurelix PFS 0.25 mg Injection 0.5 ml contains Cetrorelix that works by blocking a natural hormone in the body and inhibits premature ovulation (release of eggs from the ovary too early).
Eurelix PFS 0.25 mg Injection 0.5 ml may cause ovarian hyper-stimulation syndrome (OHSS) if used along with other medicines that cause stimulation of ovaries to develop more ready-to-be-released eggs. However, if you experience lower stomach pain with nausea or vomiting, please consult a doctor as these might be signs of OHSS.
Eurelix PFS 0.25 mg Injection 0.5 ml may be used in women undergoing IVF (in-vitro fertilization) treatment to prevent premature release of eggs so that mature eggs can be collected directly from ovaries. However, please consult a doctor before using Eurelix PFS 0.25 mg Injection 0.5 ml.
You are recommended to consult a doctor before using Eurelix PFS 0.25 mg Injection 0.5 ml during more than 1 menstrual cycle so that the doctor may check the benefits and risks of using Eurelix PFS 0.25 mg Injection 0.5 ml.
Eurelix PFS 0.25 mg Injection 0.5 ml may cause miscarriage, birth defects, or stillbirth. Therefore, avoid Eurelix PFS 0.25 mg Injection 0.5 ml if you are pregnant and consult a doctor.
You are advised to follow instructions given by your doctor if you are taking Eurelix PFS 0.25 mg Injection 0.5 ml at home. Inject Eurelix PFS 0.25 mg Injection 0.5 ml under the belly's skin and select different parts of your belly every day to minimize skin irritation.
Eurelix PFS 0.25 mg Injection 0.5 ml is an anti-gonadotropin-releasing hormone medicine. It is used for the prevention of premature ovulation in patients undergoing controlled ovarian stimulation.
Eurelix PFS 0.25 mg Injection 0.5 ml will usually be administered by a doctor. If you are asked to take Eurelix PFS 0.25 mg Injection 0.5 ml by yourself, follow instructions given by your doctor. The dose of Eurelix PFS 0.25 mg Injection 0.5 ml will be adjusted by your doctor based on the response.
Possible side effects of Eurelix PFS 0.25 mg Injection 0.5 ml are itching, redness, or swelling at the site of injection, headache, or nausea. If any of these side effects persist or worsen, please consult your doctor.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information